glp-1 obesity drug market news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Asia Pacific GLP-1 Agonists Weight

The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment

Risks: Increased heart rate, potential worsening of heart failure with reduced ejection fraction, and rare complications like hypoglycemia or retinopathy

The study also recorded lifestyle factors, such as current smoking status, based on patient self-reports documented in the medical histories within the EMRs dataset

From geroscience to precision geromedicine: Understanding and managing aging

This can lead to fewer blood sugar spikes and a reduced need for additional medications

Coming from low-dose semaglutide or tirzepatide